WebOfPharma · Pharmaceutical Quality · GMP

Stability Testing in Pharmaceuticals

A practical guide to stability protocols, shelf-life decisions, temperature excursions, analytical methods, OOS/OOT investigations and biologic products.

Stability study design Shelf-life evaluation Excursion assessment OOS/OOT response

Use this hub to navigate pharmaceutical stability testing: choose a focused guide for study design, data evaluation, temperature exposure, analytical testing or investigation. Each card is ready for its permanent article link when that guide is published.

Connect data to the productInterpret results using the approved protocol, product attributes, packaging, storage history and relevant acceptance criteria.

Trend the full stability profileReview assay, impurities, dissolution and other stability-indicating attributes over time, not as isolated values.

Document evidence-based decisionsInvestigate unusual results and excursions through approved quality procedures, with clear impact assessment and rationale.

Pharmaceutical stability testing at a glance

Stability studies evaluate how drug-substance or drug-product quality changes over time under defined conditions. The resulting evidence supports storage conditions, retest periods or shelf-life, as applicable. Study design and test attributes depend on the material, dosage form, container-closure system, intended market and approved regulatory commitments.

01 · PlanDefine batches, packaging, storage conditions, pull points and tests in an approved protocol.

02 · StoreMaintain controlled chambers and retain traceable records of sample and condition history.

03 · TestUse suitable stability-indicating methods and review controls, calculations and raw data.

04 · EvaluateTrend attributes, assess statistics where appropriate and investigate OOS, OOT or excursions.

05 · DecideDocument the quality impact and any shelf-life, storage, labeling or batch actions through the quality system.

Important: there is no single excursion duration, universal acceptance limit or statistical approach that applies to every product and market. Follow the current applicable guidance, approved protocol, registered commitments, validated methods and site quality procedures. A calculated MKT value alone does not establish product acceptability.

Pharmaceutical stability testing guides

Browse the ten planned guides below. Add each published URL to its card when the corresponding article is ready.

01Temperature excursions

Mean Kinetic Temperature (MKT) Calculation for Pharmaceutical Excursions: Formula, Worked Example, and Limitations

Explains the MKT approach to summarizing temperature history, walks through the calculation and shows why a single average cannot replace product-specific excursion assessment.

Thermal exposure assessmentArticle planned

02In-use stability

In-Use Stability Testing After Opening or Reconstitution: Study Design, Acceptance Criteria, and Labeling

Outlines how to design studies around realistic handling and use, select relevant tests and time points, and support product-specific in-use storage statements.

Opened and reconstituted productsArticle planned

03Chamber excursions

Stability Chamber Temperature and Humidity Excursion Assessment: GMP Investigation and Product Impact

Provides an investigation framework for reviewing sensor records, excursion duration and magnitude, chamber mapping, affected samples and product-specific stability evidence.

Chamber event investigationArticle planned

04Shelf-life statistics

ICH Q1E Shelf-Life Calculation Worked Example: Regression, Poolability, and Confidence Limits

Introduces regression-based stability evaluation, batch poolability considerations and confidence limits, with emphasis on assumptions and justified data interpretation.

Retest period and shelf-lifeArticle planned

05OOT trending

Stability OOT Investigation: Trending Assay, Dissolution, and Related Substances Data

Shows how to identify atypical stability trends, verify the data and method, review related attributes and determine when broader investigation or escalation is warranted.

Trend signal assessmentArticle planned

06OOS investigation

Stability OOS Investigation: GMP Assessment of Assay, Dissolution, and Impurity Failures

Summarizes a documented OOS response, including initial laboratory assessment, scientifically justified investigation steps, product impact and quality-unit disposition.

Specification failure responseArticle planned

07Analytical methods

Stability-Indicating HPLC Method Validation: Forced Degradation, Specificity, Mass Balance, and System Suitability

Connects forced-degradation studies with method specificity and validation, and discusses mass-balance interpretation and routine system-suitability controls.

Stability-indicating capabilityArticle planned

08Lifecycle changes

Stability Studies After Post-Approval Changes: Batch Selection, Protocol, and Commitment Testing

Reviews how to plan stability support after a manufacturing, formulation, site or packaging change, with batch selection and commitments aligned to the change assessment.

Post-approval lifecycleArticle planned

09Biologics

ICH Q5C Stability Testing for Biologics: Potency, Aggregates, Freeze-Thaw, and Acceptance Criteria

Highlights stability-profile design for biologics, including biological activity, product-specific physicochemical attributes, aggregation risks and handling stresses.

Biological product stabilityArticle planned

10Missed pull points

Missed Stability Pull Point: GMP Deviation, Data Impact, and Recovery Plan

Sets out how to document a missed or delayed pull, evaluate sample and data impact, decide on a justified recovery action and prevent recurrence without obscuring the event.

Protocol deviation managementArticle planned

Stability testing: quick answers

What does pharmaceutical stability testing establish?

Stability data show how relevant quality attributes change over time under defined storage conditions. They support scientifically justified storage conditions and a retest period or shelf-life, as applicable.

Can MKT alone determine whether an excursion is acceptable?

No. MKT is one way to summarize temperature exposure. A decision also needs the complete excursion history, product and packaging knowledge, study data, approved limits and the applicable quality procedure.

Is an OOT result automatically an OOS?

No. OOT describes a result or trend that is atypical against an expected pattern; it may still meet specification. Evaluate and document it under the approved trending and investigation procedures.

Do the same stability criteria apply in every market?

Not necessarily. Apply the currently adopted guidance and registered commitments for the target market, together with the approved product specification, protocol and site procedures.

Official references

Use current adopted guidance and the applicable regional requirements for regulatory or product decisions.

• ICH Q1A(R2): Stability Testing of New Drug Substances and Products
• ICH Q1E: Evaluation of Stability Data
• ICH Q5C: Stability Testing of Biotechnological/Biological Products
• FDA Guidance: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production

This page is a topic hub. Each guide is marked as planned until its article is published; replace the status in the matching card with that guide’s permanent URL.